Infection risk in autoimmune hematological disorders with low‐dose rituximab treatment

BACKGROUND: Rituximab has been widely used in many autoimmune diseases. AIM: To evaluate the infection risk of rituximab in autoimmune hematological disorders. METHODS: Retrospectively studied and compared the clinical data of 89 patients in our hospital who used low‐dose rituximab (group R) or puls...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Honglei, Yan, Siyang, Liu, Hui, Li, Lijuan, Song, Jia, Wang, Guojin, Wang, Huaquan, Wu, Yuhong, Shao, Zonghong, Fu, Rong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7595891/
https://www.ncbi.nlm.nih.gov/pubmed/32794271
http://dx.doi.org/10.1002/jcla.23455

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7595891/
https://www.ncbi.nlm.nih.gov/pubmed/32794271
http://dx.doi.org/10.1002/jcla.23455

Ejemplares similares